Deep Rx
Pittsburgh, US · Delaware corporation
Find your way into Deep Rx
Sign up to see every warm intro you have to Deep Rx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deep Rx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
LC
Lujia ChenExecutive
WF

Wensheng FanExecutiveWensheng Fan is CEO of Deep Rx, which develops COLOXIS, an AI-powered chemotherapy drug-selection tool for colorectal cancer. Previously, he co-founded and led Spectral MD, bringing the FDA Breakthrough-designated DeepView® imaging diagnostic platform from concept to commercialization; he secured over $250M in federal contracts and $39M in commercial funding, and took the company to IPO on the London Stock Exchange in 2021 and NASDAQ in 2023. Earlier roles included positions in imaging for autonomous vehicles at Sensata Technologies, wireless communications at Navini Networks, and speech recognition at PureSpeech Inc. He holds an MSEE degree.
MS
Min SunNamed on SEC filing
XL
Xinghua LuNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2024
▶$700KraisedJun 2025 · 3 investors · Other Health CareRule 506(b)
▶$700KraisedJun 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Min SunExecutive Officer, Director, Promoter
- Lujia ChenExecutive Officer, Director
- Wensheng FanExecutive Officer, Director
- Xinghua LuExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $700K
- Minimum investment
- $25K
- Proceeds to insiders
- $161K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Deep Rx raised?
- Deep Rx has disclosed $700K raised across 1 round.
- Where is Deep Rx headquartered?
- Deep Rx is headquartered in Pittsburgh, US.